IMUC

EOM Pharmaceuticals Holdings, Inc.

OTC Markets OTCPKUSDEQUITY DELAYED

0.20

■ 0.00 (0.00%)

MARKET · —

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw

Open

0.20

Prev close

0.20

Day high

0.20

Day low

0.20

Volume

Market cap

—

P/E (TTM)

—

52W range

0.04 – 0.34

Trailing performance

Price return · vs SPY

Returnvs SPY

0.00% +1.4%

-19.35% -23.1%

+73.91% +70.8%

+81.82% +70.8%

YTD

+181.69% +169.4%

+102.02% +82.0%

-20.00% -94.2%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on IMUC open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Create free account Sign in

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

0.18

+9.17% from price

SMA 20

0.19

+4.99% from price

SMA 50

0.20

-2.31% from price

SMA 100

0.17

+18.08% from price

SMA 200

0.16

+23.23% from price

EMA 12

0.18

+9.27% from price

EMA 26

0.19

+4.98% from price

EMA 50

0.19

+5.40% from price

RSI (14)

51.2

Neutral

MACD (12,26,9)

-0.01

Hist -0.00

ATR (14)

0.04

18.11% of price

Realised vol 30D

451.4%

Annualised

Bollinger upper

0.28

20, 2σ

Bollinger lower

0.10

20, 2σ

50 / 200 cross

Golden

0.20 vs 0.16

Trend bias

Above 200

+23.23%

Options chain

Account required

ExpirySpot 0.20

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Risk profile

Daily returns · 1Y window

Beta vs SPY

-1.06

Less volatile than market

Correlation to SPY

-0.03

Largely independent

Realised vol 30D

451.4%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-71.7%

Peak to trough

Max drawdown 5Y

-95.4%

Peak to trough

ATR 14

0.04

18.11% of price

Beta (reported)

—

5Y monthly, from filing

Headlines

IMUC · links out to the publisher

EOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer Patients GlobeNewswire · 88d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.